Motoshi Suzuki

Dr. Motoshi Suzuki

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2016 in Nature Communications
Verified
Journal Article
Open access
TYTomoya Yamaguchi
Tomoya Yamaguchi
CLCan Lu
Can Lu
LILisa Ida
Lisa Ida
KYKiyoshi Yanagisawa
Kiyoshi Yanagisawa
JUJiro Usukura
Jiro Usukura
TTTakashi Takahashi
Takashi Takahashi
The receptor tyrosine kinase-like orphan receptor 1 (ROR1) sustains prosurvival signalling directly downstream of the lineage-survival oncogene NKX2-1/TTF-1 in lung adenocarcinoma. Here we report an unanticipated function of this receptor tyrosine kinase (RTK) as a scaffold of cavin-1 and caveolin-1 (CAV1), two essential structural components of caveolae. This kinase-independent function of ROR1 facilitates the interactions of cavin-1 and CAV1 at the plasma membrane, thereby preventing the lysosomal degradation of CAV1. Caveolae structures and prosurvival signalling towards AKT through multiple RTKs are consequently sustained. These findings provide mechanistic insight into how ROR1 inhibition can overcome EGFR–tyrosine kinase inhibitor (TKI) resistance due to bypass signalling via diverse RTKs such as MET and IGF-IR, which is currently a major clinical obstacle. Considering its onco-embryonic expression, inhibition of the scaffold function of ROR1 in patients with lung adenocarcinoma is an attractive approach for improved treatment of this devastating cancer.

30 July 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TKTaisuke Kajino
Taisuke Kajino
TSTeppei Shimamura
Teppei Shimamura
SGShuyi Gong
Shuyi Gong
KYKiyoshi Yanagisawa
Kiyoshi Yanagisawa
LILisa Ida
Lisa Ida
TTTakashi Takahashi
Takashi Takahashi
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

9 September 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
MSMotoshi Suzuki
Motoshi Suzuki
KCKe Cao
Ke Cao
SKSeiichi Kato
Seiichi Kato
NMNaoki Mizutani
Naoki Mizutani
KTKouji Tanaka
Kouji Tanaka
TTTakashi Takahashi
Takashi Takahashi
Sphingolipids constitute a class of bio‐reactive molecules that transmit signals and exhibit a variety of physical properties in various cell types, though their functions in cancer pathogenesis have yet to be elucidated. Analyses of gene expression profiles of clinical specimens and a panel of cell lines revealed that the ceramide synthase gene CERS6 was overexpressed in non–small‐cell lung cancer (NSCLC) tissues, while elevated expression was shown to be associated with poor prognosis and lymph node metastasis. NSCLC profile and in vitro luciferase analysis results suggested that CERS6 overexpression is promoted, at least in part, by reduced miR‐101 expression. Under a reduced CERS6 expression condition, the ceramide profile became altered, which was determined to be associated with decreased cell migration and invasion activities in vitro. Furthermore, CERS6 knockdown suppressed RAC1‐positive lamellipodia/ruffling formation and attenuated lung metastasis efficiency in mice, while forced expression of CERS6 resulted in an opposite phenotype in examined cell lines. Based on these findings, we consider that ceramide synthesis by CERS6 has important roles in lung cancer migration and metastasis.

21 December 2009 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MMMasashi Murakami
Masashi Murakami
HIHiromi Ito
Hiromi Ito
KHKazumi Hagiwara
Kazumi Hagiwara
KYKayo Yoshida
Kayo Yoshida
SSSayaka Sobue
Sayaka Sobue
TMTakashi Murate
Takashi Murate
Ceramide is the central lipid in the sphingolipid metabolism. Ceramide kinase (CERK) and its product, ceramide 1‐phosphate, have been implicated in various cellular functions. However, the regulatory mechanism of CERK gene expression remains to be determined. Here, we examined CERK mRNA level during all‐trans retinoic acid (ATRA)‐induced differentiation of a human neuroblastoma cell line, SH‐SY5Y. ATRA reduced CERK mRNA and protein levels. Over‐expression and small interfering RNA (siRNA) of CERK revealed that CERK is inhibitory against ATRA‐induced neuronal differentiation and cell growth arrest. ATRA inhibited the transcriptional activity of 5′‐promoter of CERK. Truncation and mutation study suggests that ATRA‐responsible region was mainly located in the tandem retinoic acid responsive elements (RARE) between −40 bp and the first exon. The electrophoresis mobility shift assay revealed that ATRA produced two retarded bands, which were erased by antibody against chicken ovalbumin upstream promoter transcription factor I (COUP‐TFI), RARα, and RXRα, respectively. DNA pull‐down assay confirmed increased binding of these transcription factors to RARE. Transient expression of RAR, RXR, and COUP‐TFI and siRNA transfection of these genes revealed that COUP‐TFI inhibited CERK mRNA. Furthermore, chromatin immunoprecipitation assay showed the recruitment of co‐repressors as well as three transcription factors. These results suggest that COUP‐TFI was the ATRA‐responsive suppressive transcription factor of CERK gene transcription.

20 March 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
TYTomoya Yamaguchi
Tomoya Yamaguchi
MHMiyu Hayashi
Miyu Hayashi
LILisa Ida
Lisa Ida
MYMasatoshi Yamamoto
Masatoshi Yamamoto
CLCan Lu
Can Lu
TTTakashi Takahashi
Takashi Takahashi

13 February 2017 in Oncogene
Verified
Journal Article
Closed access
PDF file
ZLZ Liu
Z Liu
KYK Yanagisawa
K Yanagisawa
SGS Griesing
S Griesing
MIM Iwai
M Iwai
KKK Kano
K Kano
TTT Takahashi
T Takahashi